CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamori, Y.
Right arrow Articles by Kosaka, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamori, Y.
Right arrow Articles by Kosaka, Y.

Canadian Journal of Anesthesia, Vol 43, 1175-1179, Copyright © 1996 by Canadian Anesthesiologists' Society

ARTICLES

Antinociceptive effects of ONO-9902, an enkephalinase inhibitor, after visceral stress condition in rats

Y Yamamori, Y Saito, M Kaneko, Y Kirihara, S Sakura and Y Kosaka
Department of Anesthesiology, Shimane Medical University, Izumo, Japan.

PURPOSE: The present study was designed to examine the antinociceptive effects of orally administered ONO-9902, an enkephalinase inhibitor, on both somatic and visceral pain after visceral stress conditions. METHODS: Twenty six male rats were examined. Tail-flick (TF) and colorectal distension (CD) tests were used to determine somatic and visceral antinociceptive effects, respectively. Measurements were performed in rats under immediate post-stress conditions (group ST; n = 14) and in rats nor under stress conditions (group NST; n = 12). In the stressed group, the same device, CD, for visceral antinociceptive effects was used for visceral stress and was applied with an intracolonic pressure of 60 mmHg for 20 min after drug administration. The TF latency and CD threshold were measured before and at 30, 40, 50, 60 and 90 min after administration of ONO-9902 300 mg.kg-1 or distilled water. RESULTS: Orally administered ONO-9902 did not produce any changes in the % maximum possible effect (%MPE) in either TF or CD tests in the unstressed group. In the stressed group, %MPE in the CD test increased 18% and 31% at 30 and 40 min, respectively, after oral administration of ONO-9902 compared with the control group (P < 0.05). However, %MPE to TF test did not alter even after the CD-induced stress condition. CONCLUSION: These results suggest that ONO-9902 may have analgesic effects on visceral pain but not on somatic pain under immediate post-stress conditions.


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
D. Le Bars, M. Gozariu, and S. W. Cadden
Animal Models of Nociception
Pharmacol. Rev., December 1, 2001; 53(4): 597 - 652.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Maki, Y. Nasa, F. Yamaguchi, H. Yoshida, M. Mori, T. Takada, E. Horikawa, K. Okano, and S. Takeo
Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure
Cardiovasc Res, August 15, 2001; 51(3): 608 - 617.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Canadian Anesthesiologists' Society.